Research Grants Awarded to RCID Members
The Research Centre for Infectious Diseases has been awarded more than $41 million dollars in competitive research funding since it was established in 2008.
This has enabled the RCID to remain focused as one of the most research intensive centres at University of Adelaide.
| Applicants | Years | Funding Body | Project | Funded Amount |
|---|---|---|---|---|
|
2015 | DVCR Interdisciplinary Research Fund | Next generation metalloproteomics | $28,000 |
|
2015 | DVCR Interdisciplinary Research Fund | Bioruptor Plus | $50,000 |
|
2015-2019 | NHMRC Program Grant | Proteins and glycans in host-pathogen interactions: targets for novel drugs and vaccines | $8,795,785 |
|
2015-2017 | ARC Discovery Grant | The critical role of bacterial poly-histidine triad proteins in zinc recruitment. | $384,300 |
|
2015-2018 | NHMRC Project Grant | Novel perspectives on the function of AB5 toxin B subunits | $1,002,230 |
|
2015-2017 | NHMRC Project Grant | The molecular basis for manganese uptake by pathogenic bacteria | $613,134 |
|
2015 | Channel 7 Children's Research Foundation | Investigation of a novel protein tyrosine phosphatase in Streptococcus pneumoniae | $35,000 |
|
2015 | The Australian Institute of Nuclear Science and Engineering | Gamma-irradiated virus vaccines: concepts and parameters | $13,250 |
|
2014-2018 | NHMRC Program Grant | Hepatitis C infection: epidemiology pathogenesis and treatment | $5,427,855 |
|
2014-2016 | ARC DECRA Fellowship | The molecular determinants of biofilm formation in Streptococcus pneumoniae: novel targets for vaccines and therapeutics. | $395,220 |
|
2014 | IPAS Extending Collaborations Pilot Projects | Towards a light-driven, biocompatible sensor for the rapid detection of bacterial toxins | $16,000 |
|
2013-2017 | NHMRC | Senior Principal Research Fellowship | $808,375 |
|
2013 | Clive and Vera Ramaciotti Foundation Equipment Grant | Zetasizer Nano ZSP for protein characterisation and drug discovery | $67,595 |
|
2013 | IPAS Extending Collaborations Pilot Projects | Development of a photoswitchable, membrane-based metal ion sensing platform | $8,500 |
|
2013 | Channel 7 Children’s Research Foundation | The role of a Type I secretion system in Pseudomonas aeruginosa biofilm formation | $31,000 |
|
2013-2015 | NHMRC Project Grant | Capsule synthesis and yyrosine phosphorylation in Streptococcus pneumoniae |
$567,767 |
|
2012-2015 | ARC Linkage Grant | A single vaccine for influenza and pneumonia. | $276,000 |
|
2012-2013 | Garnett Passe & Rodney Williams Foundation - Training Fellowship | The molecular determinants of biofilm formation in Streptococcus pneumoniae: novel targets for vaccines and therapeutics. | $150,000 |
|
2012 | Clive and Vera Ramaciotti Foundation Equipment Grant | Sub-cellular particle analysis instrumentation for drug discovery | $54,783 |
|
2012 | NHMRC Equipment Grant | Temperature controlled protein purification system | $62,042 |
|
2012-2013 | Channel 7 Children’s Research Foundation | NTHi and its biofilm formation | $68,000 |
|
2012 | Channel 7 Children’s Research Foundation | The search for novel inhibitors of capsule synthesis in Streptococcus pneumoniae | $35,000 |
|
2012-2014 | ARC Discovery Grant and DORA Fellowship | Novel perspectives on the function of AB5 toxin B subunits | $860,000 |
|
2012-2014 | NHMRC Project Grant | The roles of manganese and zinc in host-pathogen interaction | $568,375 |
|
2012-2014 | NHMRC Project Grant | Imaging the hepatitis C virus life cycle in living cells | $461,325 |
|
2012-2014 | ARC Discovery Grant | The molecular basis for bacterial susceptibility to zinc. | $255,000 |
|
2012-2014 | ARC Discovery Grant | Functional characterization of poly-histidine triad proteins. | $275,000 |
|
2012 | Merck Investigator Studies Program | Analysis of Boceprevir drug susceptibility and resistance in HCV genotype 6 | $115,000 |
|
2011 | NHMRC Equipment Grant | Ultracentrifuge | $78,000 |
|
2011 | Australian Cystic Fibrosis Foundation: PG studentship | The role of ABC transporters in Pseudomonas aeruginosa multidrug resistance | $15,000 |
|
2011-2012 | ACH2 | Phase II. Development of a laboratory based platform to manage patients who develop antiviral drug-resistance to the STAT-C compounds | $113,000 |
|
2010-2011 | Bill and Melinda Gates Foundation Grand Challenge Explorations | A toxin-binding probiotic for prevention of ETEC diarrhea | $110,000 |
|
2010-2014 | NHMRC Senior Research Fellowship | $560,000 | |
|
2010-2011 | Channel 7 Children’s Research Foundation | The role of manganese in the virulence and pathogenicity of Pseudomonas aeruginosa | $98,000 |
|
2010-2011 | Dept Industry, Innovation, Science and Technology; Australia- China Special Fund for Scientific and Technological Cooperation |
New medicines for important infectious diseases | $198,591 |
|
2010 | Australian Cancer Research Foundation | South Australian Cancer Genome Facility | $3,500,000 |
|
2010-2014 | NHMRC Project Grant | Molecular analysis of pneumococcal pathogenesis. | $1,068,030 |
|
2010-2014 | NHMRC Program Grant | Pathogenesis, treatment and prevention of bacterial infectious diseases. | $9,427,000 |
|
2010-2011 | ACH2 | Development of a laboratory based platform to manage patients who develop antiviral drug-resistance to the STAT-C compounds | $142,000 |
|
2010-2011 | Roche Pillar Award | Ultra-deep sequencing of hepatitis C and hepatocytes following interferon exposure | $40,000 |
|
2009-2013 | NHMRC Program Grant | HIV and HCV Vaccines and Immunopathogenesis | $17,800,000 |
|
2009 | NHMRC Equipment Grant | Bacterial cell lysis system | $27,000 |
|
2009-2011 | ARC Linkage | Environmental genomics: mining, climate change, water, crime and health. | $500,000 |
|
2009 | NHMRC Project Grant | Intra- and intercellular spreading in Shigella pathogenesis | $168,750 |
|
2009 | NHMRC Development Grant | Proof of concept studies on a novel class of antibiotics | $196,000 |
|
2009 | Faculty of Health Sciences Research Development Award | Mechanism of LPS O antigen biosynthesis in Shigella and E. coli | $12,000 |
|
2009 | Adelaide Research and Innovation Commercial Accelerator Scheme | Proof of concept studies on a novel class of antibiotics | $250,000 |
|
2009-2011 | NHMRC Project Grant | The molecular physiology of Streptococcus pneumoniae during sepsis | $568,135 |
| CJ Sumby, JA Carver, JC Wallace, M Hrmova, A Pring, AD Abell, GW Booker, MI Bruce, J Brugger, CM Ford, HH Harris, JC Morris, JC Paton, DJ Peet, SM Pyke, KE Shearwin, RI Menz, CA Abbott, PA Anderson, MH Brown, MR Johnston, KA Schuller, AF Lopez, SM Pitson, SF Lincoln, RA McKinnon | 2009 | ARC LIEF | South Australian Facility for Small and Large Molecule X-Ray Diffraction Structure Determination | $560,000 |
|
2009-2012 | NHMRC Project Grant | Virulence strategies of LEE-negative Shiga toxigenic Escherichia coli | $744,455 |
|
2008-2010 | NHMRC Project Grant | Identification of interferon stimulated genes that limit HCV replication and predict therapeutic outcome | $468,750 |
|
2008 | NHMRC Equipment Grant | Facility for in vivo transcriptional analysis of the host-pathogen interaction | $61,000 |
|
2008 | Channel 7 Children’s Research Foundation | Treatment and/or prevention of pneumococcal disease by designing novel drugs targeting capsule biosynthesis proteins CpsB and CpsD | $50,417 |
|
2008-2010 | PATH Vaccine Solutions | Trivalent pneumococcal protein vaccine: Preclinical optimization, GMP production and Phase I US trial | $650,000 |
|
2008-2010 | PATH Vaccine Solutions | Pneumococcal vaccine candidates: Efficacy tests in animals | $840,000 |
|
2008-2011 | Meningitis Research Foundation (UK) | Chracterization and vaccine potential of pneumococcal virulence factors expressed during meningitis | $437,000 |
|
2007-2012 | NHMRC | Australia Fellowship | $4,000,000 |
|
2006-2011 | NIH | Characterization of a novel AB5 cytotoxin | $1,400,000 |